An ambitious project to promote health, well-being and quality of life globally, starting from Sardinia, a symbolic place of longevity in the world. It all started with Nuraxi, the “AI Longevity Company”, which uses funding of approximately 2.6 million euros obtained through the PNRR. With an international team in the field, Nuraxi consolidates a branch dedicated to life sciences in Sardinia, with the aim of making the island a strategic point of reference for health-tech and bio-inspired innovation.
The heart of the project is SABA – Sardinian Aging Biomarkers Analysis, a study that focuses on the creation of personalized health models, based on the analysis of factors that favor quality aging. Nuraxi develops intelligent technologies to better understand the mechanisms of longevity and return this knowledge in the form of useful tools for everyone. The relationship with institutions of excellence, such as the University of Sassari, and with international partners active in the United Kingdom, Saudi Arabia, Turkey, Switzerland and the United States, is very close, to bring bio-inspired innovation from Sardinia to the world. Appointment in Cagliari on Thursday 26 June, from 3 to 6 pm, at The Net Value (Viale La Plaia 15). The scientific and institutional community can discover the vision, technologies and prospects of this project. Speakers include Zeljko Kraljevic, University College London, Ahmed Aldemerdash, Nuraxi Saudi Arabia / Saudi Commission for Health Specialties, Ali Akca, Medical Director, Kendine İyi Bak in Turkey, Alicja Dudek, Longevity Center (Switzerland) and Luca Foschini, CEO Sage Bionetworks (USA).
